trimethoprim has been researched along with Bacteremia in 14 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tension pneumocephalus should be included in the differential diagnosis of nontraumatic hemiparesis for emergent evaluation and management." | 1.46 | Aspergillus Terreus Brain Abscess Complicated by Tension Pneumocephalus in a Patient with Angiosarcoma. ( Fernandez, J; Nanjappa, S; Pabbathi, S; Srikumar, T, 2017) |
| "Ampicillin resistance was relatively stable over time, but varied between Health Regions." | 1.31 | Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. ( George, RC; Gifford, T; James, D; Johnson, AP; Livermore, DM; Northcott, D; Speller, DC; Stephens, P; Weinberg, J, 2000) |
| "aureus bacteremia were compared against 188 controls selected from patients with CD4 cell counts < 200 x 10(6)/l." | 1.30 | Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. ( Chaisson, RE; Moore, RD; Styrt, BA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TH | 1 |
| Chuang, YC | 1 |
| Wang, JT | 1 |
| Sheng, WH | 1 |
| McCowan, C | 1 |
| Bakhshi, A | 1 |
| McConnachie, A | 1 |
| Malcolm, W | 1 |
| Barry, SJ | 1 |
| Santiago, VH | 1 |
| Leanord, A | 1 |
| Mokraoui, NR | 1 |
| Ganim, R | 1 |
| Paez, A | 1 |
| Iki, Y | 1 |
| Hata, A | 1 |
| Fukuyama, M | 1 |
| Yoshioka, T | 1 |
| Watanabe, K | 1 |
| Asari, S | 1 |
| Hata, D | 1 |
| Watson, L | 1 |
| Esterly, J | 1 |
| Jensen, AO | 1 |
| Postelnick, M | 1 |
| Aguirre, A | 1 |
| McLaughlin, M | 1 |
| Lishman, H | 1 |
| Costelloe, C | 1 |
| Hopkins, S | 1 |
| Johnson, AP | 2 |
| Hope, R | 1 |
| Guy, R | 1 |
| Muller-Pebody, B | 1 |
| Holmes, A | 1 |
| Aylin, P | 1 |
| Rijnders, B | 1 |
| DiSciullo, GJ | 1 |
| Csiky, B | 1 |
| Rutkowski, B | 1 |
| Appelt, K | 1 |
| Cheronis, J | 1 |
| Aitchison, R | 1 |
| Gordon, G | 1 |
| Jadoul, M | 1 |
| Fluck, R | 1 |
| Vinker-Shuster, M | 1 |
| Stepensky, P | 1 |
| Temper, V | 1 |
| Shayovitz, V | 1 |
| Masarwa, R | 1 |
| Averbuch, D | 1 |
| Kuretski, J | 1 |
| Dahya, V | 1 |
| Cason, L | 1 |
| Chalasani, P | 1 |
| Ramgopal, M | 1 |
| Srikumar, T | 1 |
| Pabbathi, S | 1 |
| Fernandez, J | 1 |
| Nanjappa, S | 1 |
| Melendez, J | 1 |
| Claxton, A | 1 |
| Erskine, K | 1 |
| Styrt, BA | 1 |
| Chaisson, RE | 1 |
| Moore, RD | 1 |
| Pedersen, G | 1 |
| Schønheyder, HC | 1 |
| Steffensen, FH | 1 |
| Sørensen, HT | 1 |
| Livermore, DM | 1 |
| Stephens, P | 1 |
| Weinberg, J | 1 |
| Gifford, T | 1 |
| Northcott, D | 1 |
| James, D | 1 |
| George, RC | 1 |
| Speller, DC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation to Evaluate the Safety and Effectiveness of B-Lock™ as an Antimicrobial Catheter Lock Solution in Dialysis Patients With a Central Venous C[NCT01989091] | Phase 3 | 270 participants (Actual) | Interventional | 2012-07-31 | Terminated (stopped due to Did not meet predetermined primary endpoint) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for trimethoprim and Bacteremia
| Article | Year |
|---|---|
Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Local; Bac | 2019 |
Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome.
Topics: Adolescent; Allografts; Bacteremia; Child; Child, Preschool; Drug Combinations; Drug Resistance, Bac | 2019 |
12 other studies available for trimethoprim and Bacteremia
| Article | Year |
|---|---|
Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Burkholderia cepacia complex; | 2022 |
E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Drug Res | 2022 |
Chest wall abscess and costochondritis due to Salmonella enterica serotype Choleraesuis: a case report.
Topics: Abscess; Aged; Bacteremia; Female; Gastrointestinal Diseases; Humans; Salmonella; Salmonella enteric | 2023 |
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Bacteremia; Clindamycin; Conservative Treatment; Drug Com | 2019 |
Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Female; Fluoroquinolones; | 2018 |
Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Engla | 2018 |
Nocardia Bacteremia and Endocarditis in a Patient With a Sulfa Allergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Hypersensitivity; Dyspnea; Endocard | 2016 |
Aspergillus Terreus Brain Abscess Complicated by Tension Pneumocephalus in a Patient with Angiosarcoma.
Topics: Aged; Anti-Bacterial Agents; Aspergillosis; Aspergillus; Bacteremia; Brain Abscess; Cefepime; Cephal | 2017 |
MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Cesarean Sec | 2012 |
Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Case-Control Studie | 1997 |
Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemia.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Denmark; Drug Pr | 1999 |
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacteremia; Drug Prescriptions; D | 2000 |